ArticleMolecular medicine reports2019

miR‑145 suppresses ovarian cancer progression via modulation of cell growth and invasion by targeting CCND2 and E2F3.

Minhui Hua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.